To the Editor In his recent editorial, Dr Hayes correctly noted that "analytical validity and clinical utility" are needed for the adoption of a tumor biomarker test into clinical care. However, proving analytical validity with correlative or concordance studies is largely irrelevant without first proving clinical utility.
https://ift.tt/2L4UX1A
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου